Patents by Inventor Jayhyuk Myung

Jayhyuk Myung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tablet and method of preparing the same
    Patent number: 10420728
    Abstract: Disclosed is a method for preparing a tablet. The method can improve the compressibility of the active ingredients and produce tablets of uniform quality, bringing about the advantage of increasing tablet hardness with an increase in compression pressure, easily controlling disintegration time, and decreasing tablet friability by using the active ingredient fimasartan, a pharmaceutically acceptable salt thereof or a hydrate or solvate thereof having a specific particle size distribution.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: September 24, 2019
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Jayhyuk Myung, Sung Chan Jeong, Yun Sam Kim
  • TABLET AND METHOD OF PREPARING THE SAME
    Publication number: 20180015043
    Abstract: Disclosed is a method for preparing a tablet. The method can improve the compressibility of the active ingredients and produce tablets of uniform quality, bringing about the advantage of increasing tablet hardness with an increase in compression pressure, easily controlling disintegration time, and decreasing tablet friability by using the active ingredient fimasartan, a pharmaceutically acceptable salt thereof or a hydrate or solvate thereof having a specific particle size distribution.
    Type: Application
    Filed: January 11, 2016
    Publication date: January 18, 2018
    Applicant: Boryung Pharmaceutical Co., Ltd
    Inventors: Jayhyuk Myung, Sung Chan Jeong, Yun Sam Kim
  • Pharmaceutical combination drug
    Patent number: 9592233
    Abstract: Provided is a pharmaceutical combination preparation including fimasartan and rosuvastatin as active ingredients together with meglumine. The combination preparation exhibits an outstanding effect in treating cardiovascular disease by improving the disintegration and the dissolution which obtained better drug bioavailability and drug safety.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 14, 2017
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Jayhyuk Myung, Kyung Wan Nam, Cheol Woo Lee, Ju Won Kim
  • PHARMACEUTICAL COMBINATION DRUG
    Publication number: 20160022679
    Abstract: The present invention relates to a pharmaceutical combination preparation comprising fimasartan and rosuvastatin as active ingredients together with meglumine. The combination preparation of the present invention exhibits an outstanding effect in treating cardiovascular disease by improving the disintegration and the dissolution which obtained better drug bioavailability and drug safety.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Applicant: Boryung Pharmaceutical Co., Ltd.
    Inventors: Jayhyuk MYUNG, Kyung Wan NAM, Cheol Woo LEE, Ju Won KIM
  • FLAVIN DERIVATIVES
    Publication number: 20120295903
    Abstract: The present invention relates novel flavin derivatives and other flavin derivatives, their use and compositions for use as riboswitch ligands and/or anti-infectives. The invention also provides method of making novel flavin derivatives.
    Type: Application
    Filed: June 30, 2010
    Publication date: November 22, 2012
    Inventors: Kenneth F. Blount, Philip D.G. Coish, Brian R. Dixon, Jayhyuk Myung, David Osterman, Phil Wickens, Stephanie Avola, Nick Baboulas, Angelica Bello, Judd Berman, Harpreet Kaur, David Moon, Vinh Pham, Andrew Roughton, Jeffrey Wilson, Jeffrey A. Leiby, Dennis Underwood, Paul Adrian Aristoff, Heinrich J. Schostarez, Robert A. Chrusciel, Thomas R. Belliotti, Bruce R. Evans, Frank C. Sciavolino, Manuel A. Navia
  • METHODS FOR SCREENING AND IDENTIFYING COMPOUNDS
    Publication number: 20120135417
    Abstract: Methods, compositions and assays that measure the effect of a test compound on induction of ligand-induced ribowitch-mediated transcription termination are disclosed. The methods and the assays are useful in identifying drug candidates that modulate transcription by binding to a riboswitch, for example.
    Type: Application
    Filed: June 2, 2010
    Publication date: May 31, 2012
    Inventors: Jayhyuk Myung, Kenneth F. Blount, Christen Douglas Forbes, David Osterman
  • FLAVIN DERIVATIVES
    Publication number: 20120077781
    Abstract: The present invention relates novel flavin derivatives and other flavin derivatives, their use and compositions for use as riboswitch ligands and/or anti-infectives. The invention also provides method of making novel flavin derivatives.
    Type: Application
    Filed: August 11, 2009
    Publication date: March 29, 2012
    Inventors: Robert Gadwood, Harpreet Kaur, Kevin Kells, Jeffrey A. Leiby, David Moon, Vinh Pham, Philip D.G. Coish, Kenneth F. Blount, Brian R. Dixon, Jayhyuk Myung, David Osterman, Stephanie Avola, Nick Baboulas, Angelica Bello, Judd Berman, Bruce R. Evans, Tan Quach, Heinrich J. Schostarez, Frank C. Sciavolino, Dennis Underwood, Phil Wickens, Jeffrey Wilson, Justin Wu